Enanta Pharmaceuticals (ENTA) Capital Expenditures Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -99.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.41% |
| Dec 31, 2025 | -98.36% |
| Sep 30, 2025 | -0.28% |
| Jun 30, 2025 | -349.61% |
| Mar 31, 2025 | 52.16% |
| Dec 31, 2024 | 1,011.18% |
| Sep 30, 2024 | 742.98% |
| Jun 30, 2024 | 84.15% |
| Mar 31, 2024 | -30.00% |
| Dec 31, 2023 | -75.06% |
| Sep 30, 2023 | 159.58% |
| Jun 30, 2023 | 756.97% |
| Mar 31, 2023 | 509.46% |
| Dec 31, 2022 | 6,760.87% |
| Sep 30, 2022 | -28.20% |
| Jun 30, 2022 | 183.11% |
| Mar 31, 2022 | 200.77% |
| Dec 31, 2021 | -75.53% |
| Sep 30, 2021 | 761.26% |
| Jun 30, 2021 | -258.95% |
| Mar 31, 2021 | 134.30% |
| Dec 31, 2020 | -61.48% |
| Sep 30, 2020 | -137.50% |
| Jun 30, 2020 | -91.48% |
| Mar 31, 2020 | -123.88% |
| Dec 31, 2019 | -62.58% |
| Sep 30, 2019 | 588.37% |
| Jun 30, 2019 | 287.71% |
| Mar 31, 2019 | 38.60% |
| Dec 31, 2018 | 1,074.77% |
| Sep 30, 2018 | -81.62% |
| Jun 30, 2018 | -260.32% |
| Mar 31, 2018 | 98.10% |
| Dec 31, 2017 | -88.35% |
| Sep 30, 2017 | 106.35% |
| Jun 30, 2017 | 20.88% |
| Mar 31, 2017 | -61.80% |
| Dec 31, 2016 | -56.62% |
| Sep 30, 2016 | -333.29% |
| Jun 30, 2016 | 53.25% |
| Mar 31, 2016 | 1,413.00% |
| Dec 31, 2015 | 758.20% |
| Sep 30, 2015 | 225.77% |
| Jun 30, 2015 | 5.82% |
| Mar 31, 2015 | -29.08% |
| Dec 31, 2014 | 966.67% |
| Sep 30, 2014 | 140.10% |
| Jun 30, 2014 | 626.92% |
| Mar 31, 2014 | -58.65% |
| Dec 31, 2013 | 118.18% |
| Sep 30, 2013 | 81.98% |
| Jun 30, 2013 | 10.64% |